Needham Boosts Price Target on Natus Medical (BABY) to $28, Calls a Takeover Candidate
Tweet Send to a Friend
Needham & Co analyst Ed Shenkan raised his price target on Natus Medical (Nasdaq: BABY) from $22 to $28, reiterating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
